FLEXcyte 96 recordings in comparison to in vivo and in vitro cardiac muscle contraction via MUSCLEMOTION data
관리자
view : 512
Cells: Cardiosight®-S
Tools: FLEXcyte 96
- Home
- RESOURCES
- Application protocol
- iPSC Technology
- Korean iPSC Derived Cell Provider
- NEXEL
- ICH S7B CiPA
- Human Cardiomyocytes
- iPSC Derived Cardiomyocytes
- iPSC derived hepatocytes
- iPSC Derived Neurons
- MEA assay
- iPSC Derived Cell
- Cardiomyocyte Contractility
- 3D Tissue Contractility Analysis
- 3D Engineered Organoid Plates
- Cell Engineered Stretcher Plates
- 3D Organoid Plates
- Cell Nanosurface Plates
- Cardiac Safety Service
- hERG Assay
- Cardiotoxicity Test Screening
- Cardiomyocyte Viability
- iPSC Disease Model Service
- iPSC Reprogramming
- Drug Candidate Screening
- Drug Cardiotoxicity Test
- Disease Modeling
Beyond conventional boundaries,
we deliver a bold new paradigm.
we deliver a bold new paradigm.
-
CONTACTContact Information
- Address: 8F, 55 Magokdong-ro, Gangseo-gu, Seoul, Republic of Korea(07802)
- Business Registration No.: 109-86-37282
- CEO: Choongseong Han
- Tel : +82-2-2088-8886
- Fax: +82-2-2088-8884
- E-mail : support@nexel.co.kr